Involvement of leukemia inhibitory factor in the increases in galanin and vasoactive intestinal peptide mRNA and the decreases in neuropeptide Y and tyrosine hydroxylase mRNA in sympathetic neurons after axotomy

Journal of Neurochemistry

Volumn 67, Issue 4, 1996, Pages 1751-1760

  Sun, Y ^a,b   Zigmond, R E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Axotomy; Galanin; Leukemia inhibitory factor; Neuropeptide; Superior cervical ganglion; Tyrosine hydroxylase

Indexed keywords

GALANIN; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; NEUROPEPTIDE Y; TYROSINE 3 MONOOXYGENASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; NERVE FIBER TRANSECTION; NERVE INJURY; NERVE POTENTIAL; NEUROTRANSMITTER RELEASE; NONHUMAN; NULL CELL; PHENOTYPE; PRIORITY JOURNAL; RAT; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVE CELL; SYNAPTIC TRANSMISSION; TARGET CELL;

ANIMALIA;

EID: 0029790233     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67041751.x     Document Type: Article

References (61)

1. Anegon I., Grolleau D., and Soulillou J. P. (1991) Regulation of HILDA/LIF gene expression in activated human monocytic cells. J. Immunol. 147, 3973-3980.
2. Bai Y., Carlson C. D., Ding M., Jonakait G. M., and Hart R. P. (1994) mRNA encoding IL-1β, IL-1 receptor and IL-1 receptor antagonist are induced following sympathetic axotomy. Soc. Neurosci. Abstr. 20, 295.
3. Bamber B. A., Masters B. A., Hoyle G. W., Brinster R. L., and Palmiter R. D. (1994) Leukemia inhibitory factor induces neurotransmitter switching in transgenic mice. Proc. Natl. Acad. Sci. USA 91, 7839-7843.
4. Banner L. R. and Patterson P. H. (1994) Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia. Proc. Natl. Acad. Sci. USA 91, 7109-7113.
5. Bergsteinsdottir K., Kingston A., Mirsky R., and Jessen K. R. (1991) Rat Schwann cells produce interleukin-1. J. Neuroimmunol. 34, 15-23.
6. Bonni A., Frank D. A., Schindler C., and Greenberg M. E. (1993) Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus. Science 262, 1575-1579.
7. Clegg D. L., Bodary S. C., Large T. H., Shelton D. L., and Reichardt T. H. (1989) Quantitative measurement of nerve growth factor mRNA, in Methods in the Neurosciences (Rush R. A., ed), pp. 256-273. Wiley-Interscience, Chichester.
8. Escary J.-L., Perreau J., Dumenil D., Ezine S., and Brulet P. (1993) Leukemia inhibitory factor is necessary for maintenance of hematopoietic stem cells and thymocyte stimulation. Nature 363, 361-364.
9. Fann M. J. and Patterson P. H. (1994) Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. Proc. Natl. Acad. Sci. USA 91, 43-47.
10. Fawcett J. W. and Keynes R. J. (1990) Peripheral nerve regeneration. Annu. Rev. Neurosci. 13, 43-60.
11. Federoff H. J., Geschwind M. D., Geller A. I., and Kessler J. A. (1992) Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc. Natl. Acad. Sci. USA 89, 1636-1640.
12. Fukada K. (1985) Purification and partial characterization of a cholinergic differentiation factor. Proc. Natl. Acad. Sci. USA 82, 8795-8799.
13. Fukada K. and Towle M. F. (1992) Function-blocking antibodies generated against cholinergic neuronal differentiation factor. Neuroreport 3, 157-160.
14. Gorin P. D. and Johnson E. M. (1980) Effects of exposure to nerve growth factor antibodies on the developing nervous system of the rat: an experimental autoimmune approach. Dev. Biol. 80, 313-323.
15. Hamilton J. A., Waring P. M., and Filonzi E. L. (1993) Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha. J. Immunol. 150, 1496-1502.
16. Hendry I. A. (1975) The response of adrenergic neurons to axotomy and nerve growth factor. Brain Res. 94, 87-97.
17. Heumann R., Lindholm D., Bandtlow C., Meyer M., Radeke M. J., Misko T. P., Shooter E., and Thoenen H. (1987) Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages. Proc. Natl. Acad. Sci. USA 84, 8735-8739.
18. Hokfelt T., Johansson O., Ljungdahl A., Lundberg J. M., and Schultzberg M. (1980) Peptidergic neurons. Nature 284, 515-521.
19. Hyatt-Sachs H., Schreiber R., Bennett T., and Zigmond R. (1993) Phenotypic plasticity in adult sympathetic ganglia in vivo: effects of deafferentation and axotomy on the expression of vaso-active intestinal peptide. J. Neurosci. 13, 1642-1653.
20. Hyatt-Sachs H., Bachoo M., Schreiber R., and Zigmond R. E. (1996) Chemical sympathectomy and postganglionic nerve transection produce similar increases in mRNA for galanin and VIP but not the peptides themselves. J. Neurobiol. (in press).
21. Ishimi Y., Abe E., Jin C. H., Miyaura C., Hong M. H., Oshida M., Kurosawa H., Yamaguchi Y., Tomida M., Hozumi M., and Suda T. (1992) Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism. J. Cell. Physiol. 152, 71-78.
22. Jonakait G. M. (1993) Neural-immune interactions in sympathetic ganglia. Trends Neurosci. 16, 419-423.
23. Kessler J. A. and Black I. B. (1979) The role of axonal transport in the regulation of enzyme activity in sympathetic ganglia of adult rats. Brain Res. 171, 415-424.
24. Koo E. H., Hoffman P. N., and Price D. L. (1988) Levels of neurotransmitter and cytoskeletal protein mRNAs during nerve regeneration in sympathetic ganglia. Brain Res. 449, 361-363.
25. Lewis S. E., Rao M. S., Symes A. J., Dauer W. T., Fink J. S., Landis S. C., and Hyman S. E. (1994) Coordinate regulation of choline acetyltransferase, tyrosine hydroxylase, and neuropeptide mRNAs by ciliary neurotrophic factor and leukemia inhibitory factor in cultured sympathetic neurons. J. Neurochem. 63, 429-438.
26. Lindholm D., Heumann R., Meyer M., and Thoenen H. (1987) Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 330, 658-659.
27. Lotz M., Moats T., and Villiger P. M. (1992) Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J. Clin. Invest. 90, 888-896.
28. Lundberg J. M., Terenius L., Hokfelt T., Martling C., Tatemoto K., Mutt V., Polak J., Bloom S., and Goldstein M. (1982) Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol. Scand. 116, 477-480.
29. Lundberg J. M., Terenius L., Hokfelt T., and Goldstein M. (1983) High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci. Lett. 42, 167-172.
30. Mack D. H., Vartikar J., Pipas J. M., and Laimins L. A. (1993) Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363, 281-283.
31. Mohney R. P., Siegel R. E., and Zigmond R. E. (1994) Galanin and vasoactive intestinal peptide messenger RNAs increase following axotomy of adult sympathetic neurons. J Neurobiol. 25, 108-118.
32. Nawa H, and Sah D. W. (1990) Different biological activities in conditioned media control the expression of a variety of neuropeptides in cultured sympathetic neurons. Neuron 4, 279-287.
33. Nawa H., Yamamori T., Le T., and Patterson P. H. (1990) The generation of neuronal diversity: analogies and homologies with hematopoiesis. Cold Spring Harb. Symp. Quant. Biol. 55, 247-253.
34. Nawa H., Nakanishi S., and Patterson P. H. (1991) Recombinant cholinergic differentiation factor (leukemia inhibitory factor) regulates sympathetic neuron phenotype by alterations in the size and amounts of neuropeptide mRNAs. J. Neurochem. 56, 2147-2150.
35. Nikodijevic B., Yu M. W., and Guroff G. (1977) Effects of nerve growth factor and nerve growth factor antiserum on tyrosine hydroxylase and dihydropterine reductase activities in rat superior cervical ganglia in vivo. J. Neurochem. 28, 851-852.
36. Patterson P. H. and Chun L. L. Y. (1974) The influence of nonneuronal cells on catecholamine and acetylcholine synthesis and accumulation in cultures of dissociated sympathetic neurons. Proc. Natl. Acad. Sci. USA 71, 3607-3610.
37. Rao M., Sun Y., Vaidyanathan U., Landis S., and Zigmond R. (1993a) Regulation of substance P is similar to that of vaso-active intestinal peptide after axotomy or explantation of the rat superior cervical ganglion. J. Neurobiol. 24, 571-580.
38. Rao M. S., Sun Y., Escary J. L., Perreau J., Tresser S., Patterson P. H., Zigmond R. E., Brulet P., and Landis S. C. (1993b) Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 11, 1175-1185.
39. Rotshenker S., Aamar S., and Barak V. (1992) Interleukin-1 activity in lesioned peripheral nerve. J. Neuroimmunol. 39, 75-80.
40. Scherer S. S., Kamholz J., and Jakowlew S. B. (1993) Axons modulate the expression of transforming growth factor-betas in Schwann cells. Glia 8, 265-276.
41. Schreiber R., Hyatt-Sachs H., Bennett T. A., and Zigmond R. E. (1994) Galanin expression increases in adult rat sympathetic neurons after axotomy. Neuroscience 60, 17-27.
42. Schreiber R. C., Shadiack A. M., Bennett T. A., Sedwick C. E., and Zigmond R. E. (1995) Changes in the macrophage population of the rat superior cervical ganglion after postganglionic nerve injury. J. Neurobiol. 27, 141-153.
43. Shadiack A. M., Hart R. P., Carlson C. D., and Jonakait G. M. (1993) Interleukin-1 induces substance P in sympathetic ganglia through the induction of leukemia inhibitory factor (LIF). J. Neurosci. 13, 2601-2609.
44. Shadiack A. M., Carlson C. D., Ding M., Hart R. P., and Jonakait G. M. (1994) Lipopolysaccharide induces substance P in sympathetic ganglia via ganglionic interleukin-1 production. J. Neuroimmunol. 49, 51-58.
45. Shuai K., Ziemiecki A., Wilks A. F., Harpur A. G., Sadowski H. B., Gilman M. Z., and Darnell J. E. (1993) Polypeptide signaling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366, 580-583.
46. Stahl N. and Yancopoulos G. D. (1993) The alphas, betas and kinases of cytokine receptor complexes. Cell 74, 587-590.
47. Sun Y. (1996) Regulation and function of leukemia inhibitory factor in mature sympathetic ganglia after axotomy. Ph.D. thesis, Case Western Reserve University, January 1996.
48. Sun Y., Landis S. C., and Zigmond R. E. (1994a) Signals that induce expression of leukemia inhibitory factor (LIF) in rat superior cervical ganglion (SCG) and their nerves after axonal transection. Soc. Neurosci. Abstr. 20, 1304.
49. Sun Y., Rao M. S., Zigmond R. E., and Landis S. C. (1994b) Regulation of vasoactive intestinal peptide expression in sympathetic neurons in culture and after axotomy: the role of cholinergic differentiation factor/leukemia inhibitory factor. J. Neurobiol. 25, 415-430.
50. Symes A. J., Rao M. S., Lewis S. E., Landis S. C., Hyman S. E., and Fink J. S. (1993) Ciliary neurotrophic factor coordinately activates transcription of neuropeptide genes in a neuroblastoma cell line. Proc. Natl. Acad. Sci. USA 90, 572-576.
51. Symes A., Lewis S., Corpus L., Rajan P., Hyman S. E., and Fink J. S. (1994) STAT protein participate in the regulation of the vasoactive intestinal peptide gene by the ciliary neurotrophic factor family of cytokines. Mol. Endocrinol. 8, 1750-1763.
52. Thoenen H. and Barde Y.-A. (1980) Physiology of nerve growth factor. Physiol. Rev. 60, 1284-1335.
53. Thoenen H., Angeletti P. U., Levi M. R., and Kettler R. (1971) Selective induction by nerve growth factor of tyrosine hydroxylase and dopamine-β-hydroxylase in the rat superior cervical ganglia. Proc. Natl. Acad. Sci. USA 68, 1598-1602.
54. Verge V. M. K., Richardson P. M., Wiesenfeld-Hallin Z., and Hokfelt T. (1995) Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons. J. Neurosci. 15, 2081-2096.
55. Vrontakis M. E., Peden L. M., Duckworth M. L., and Friesen H. G. (1987) Isolation and characterization of a complementary DNA (galanin) clone from estrogen-induced pituitary tumor messenger RNA. J. Biol. Chem. 262, 16755-16758.
56. Wong J. and Oblinger M. M. (1991) NGF rescues substance P expression but not neurofilament or tubulin gene expression in axotomized sensory neurons. J. Neurosci. 11, 543-552.
57. Yamamori T., Fukada K., Aebersold R., Korsching S., Fann M. J., and Patterson P. H. (1989) The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 246, 1412-1416.
58. Zhang Q., Ji R.-R., Lindsay R., and Hokfelt T. (1995) Effect of growth factors on substance P mRNA expression in axotomized dorsal root ganglia. Neuroreport 6, 1309-1312.
59. Zigmond R., Hyatt-Sachs H., Baldwin C., Qu X., Sun Y., McKeon T., Schreiber R., and Vaidyanathan U. (1992) Phenotypic plasticity in adult sympathetic neurons: changes in neuropeptide expression in organ culture. Proc. Natl. Acad. Sci. USA 89, 1507-1511.
60. Zigmond R. E., Hyatt-Sachs H., Mohney R. P., Schreiber R. C., Shadiack A. M., Sun Y., and Vaccariello S. A. (1995a) Changes in neuropeptide phenotype after axotomy of adult peripheral neurons and the role of leukemia inhibitory factor. Perspect. Dev. Neurobiol. (in press).
61. Zigmond R. E., Shadiack A. M., and Sun Y. (1995b) Antiserum to nerve growth factor (NGF) alters neuropeptide expression in the superior cervical ganglion (SCG) and dorsal root ganglion (DRG) in vivo. Soc. Neurosci. Abstr. 21, 1052.